Wang Guohui, Yang Zeng-Quan, Zhang Kezhong
Am J Transl Res. 2010 Jan 1;2(1):65-74.
In eukaryotic cells, the endoplasmic reticulum (ER) is an organelle that is responsible for protein folding and assembly, lipid and sterol biosynthesis, and free calcium storage. In the past decade, intensive research effort has been focused on intracellular stress signaling pathways from the ER that lead to transcriptional and translational reprogramming of stressed cells. These signaling pathways, which are collectively termed Unfolded Protein Response (UPR), are critical for the cell to make survival or death decision under ER stress conditions. In recent years, research in the cancer field has revealed that ER stress and the UPR are highly induced in various tumors and are closely associated with cancer cell survival and resistance to anti-cancer treatments. Identifying the UPR components that are activated or suppressed in malignancy and exploring cancer therapeutic potentials by targeting the UPR are hot research spots. In this review, we summarize the recent progress in understating UPR signaling in cancer and its related therapeutic potential.
在真核细胞中,内质网(ER)是一种细胞器,负责蛋白质折叠与组装、脂质和固醇生物合成以及游离钙储存。在过去十年中,大量研究工作聚焦于内质网引发的细胞内应激信号通路,这些通路会导致应激细胞的转录和翻译重编程。这些信号通路统称为未折叠蛋白反应(UPR),对于细胞在应激条件下做出生存或死亡的决定至关重要。近年来,癌症领域的研究表明,内质网应激和未折叠蛋白反应在各种肿瘤中高度诱导,并且与癌细胞存活及抗癌治疗耐药性密切相关。识别在恶性肿瘤中被激活或抑制的未折叠蛋白反应成分,并通过靶向未折叠蛋白反应探索癌症治疗潜力,是热门研究方向。在本综述中,我们总结了在理解癌症中未折叠蛋白反应信号及其相关治疗潜力方面的最新进展。